Literature DB >> 30108183

Aurora-PLK1 cascades as key signaling modules in the regulation of mitosis.

Vladimir Joukov1, Arcangela De Nicolo2.   

Abstract

Mitosis is controlled by reversible protein phosphorylation involving specific kinases and phosphatases. A handful of major mitotic protein kinases, such as the cyclin B-CDK1 complex, the Aurora kinases, and Polo-like kinase 1 (PLK1), cooperatively regulate distinct mitotic processes. Research has identified proteins and mechanisms that integrate these kinases into signaling cascades that guide essential mitotic events. These findings have important implications for our understanding of the mechanisms of mitotic regulation and may advance the development of novel antimitotic drugs. We review collected evidence that in vertebrates, the Aurora kinases serve as catalytic subunits of distinct complexes formed with the four scaffold proteins Bora, CEP192, INCENP, and TPX2, which we deem "core" Aurora cofactors. These complexes and the Aurora-PLK1 cascades organized by Bora, CEP192, and INCENP control crucial aspects of mitosis and all pathways of spindle assembly. We compare the mechanisms of Aurora activation in relation to the different spindle assembly pathways and draw a functional analogy between the CEP192 complex and the chromosomal passenger complex that may reflect the coevolution of centrosomes, kinetochores, and the actomyosin cleavage apparatus. We also analyze the roles and mechanisms of Aurora-PLK1 signaling in the cell and centrosome cycles and in the DNA damage response.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30108183     DOI: 10.1126/scisignal.aar4195

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  49 in total

Review 1.  The role of aurora A and polo-like kinases in high-risk lymphomas.

Authors:  Carlos Murga-Zamalloa; Kedar V Inamdar; Ryan A Wilcox
Journal:  Blood Adv       Date:  2019-06-11

2.  The ciliopathy protein CCDC66 controls mitotic progression and cytokinesis by promoting microtubule nucleation and organization.

Authors:  Umut Batman; Jovana Deretic; Elif Nur Firat-Karalar
Journal:  PLoS Biol       Date:  2022-07-18       Impact factor: 9.593

3.  Efficacy of adavosertib therapy against anaplastic thyroid cancer.

Authors:  Yu-Ling Lu; Yu-Tung Huang; Ming-Hsien Wu; Ting-Chao Chou; Richard J Wong; Shu-Fu Lin
Journal:  Endocr Relat Cancer       Date:  2021-04-29       Impact factor: 5.678

4.  Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma.

Authors:  Mariafausta Fischietti; Frank Eckerdt; Gavin T Blyth; Ahmet D Arslan; William M Mati; Chidera V Oku; Ricardo E Perez; Catalina Lee-Chang; Ewa M Kosciuczuk; Diana Saleiro; Elspeth M Beauchamp; Maciej S Lesniak; Daniela Verzella; Leyu Sun; Eleanor N Fish; Guang-Yu Yang; Wenan Qiang; Leonidas C Platanias
Journal:  Oncogene       Date:  2021-04-12       Impact factor: 9.867

5.  Protocol to identify centrosome-associated transcription factors during mitosis in mammalian cell lines.

Authors:  Guobin Xie; Yuqi Zhou; Mingxuan Du; Qiqiang Wang; Jiajin Yi; Xiao-Kun Zhang
Journal:  STAR Protoc       Date:  2021-06-17

6.  OTUD6A Is an Aurora Kinase A-Specific Deubiquitinase.

Authors:  Hyo Jin Kim; Jongchan Kim
Journal:  Int J Mol Sci       Date:  2021-02-16       Impact factor: 5.923

Review 7.  Cell cycle control in cancer.

Authors:  Helen K Matthews; Cosetta Bertoli; Robertus A M de Bruin
Journal:  Nat Rev Mol Cell Biol       Date:  2021-09-10       Impact factor: 94.444

8.  PLK1 regulates centrosome migration and spindle dynamics in male mouse meiosis.

Authors:  Enrique Alfaro; Pablo López-Jiménez; José González-Martínez; Marcos Malumbres; José A Suja; Rocío Gómez
Journal:  EMBO Rep       Date:  2021-02-21       Impact factor: 8.807

Review 9.  Molecular insight into how γ-TuRC makes microtubules.

Authors:  Akanksha Thawani; Sabine Petry
Journal:  J Cell Sci       Date:  2021-07-23       Impact factor: 5.235

10.  Efficacy and Biomarker Analysis of Adavosertib in Differentiated Thyroid Cancer.

Authors:  Yu-Ling Lu; Ming-Hsien Wu; Yi-Yin Lee; Ting-Chao Chou; Richard J Wong; Shu-Fu Lin
Journal:  Cancers (Basel)       Date:  2021-07-12       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.